Evaluation of GC-MS for identification and characterization of pneumococcal serotype 24A, 24B, and 24F capsular polysaccharide.

GC-MS Monoclonal antibody Pneumococcal polysaccharide Stereoisomers

Journal

Biochemical and biophysical research communications
ISSN: 1090-2104
Titre abrégé: Biochem Biophys Res Commun
Pays: United States
ID NLM: 0372516

Informations de publication

Date de publication:
06 Jul 2024
Historique:
received: 20 06 2024
accepted: 04 07 2024
medline: 11 7 2024
pubmed: 11 7 2024
entrez: 10 7 2024
Statut: aheadofprint

Résumé

Analysis of pneumococcal polysaccharides (PnPs) has been an arduous task, especially in similar serotypes. Pneumococci invades the host immune response by modulating capsule structure with small genetic changes making them indistinguishable from similar serotypes by conventional modes of analysis. The new serotype 24F causing invasive pneumococcal-resistant infection is an analytical challenge for its analysis as related serotypes 24A and 24B Ps share a common backbone. The difference in the branched chain which contains arabinitol and ribitol in 24F and 24B respectively are stereoisomers making their identification even more challenging. The composition analysis by GC-MS revealed distinct peaks for arabinitol in 24F and 24A Ps and ribitol in Pn 24B serotype polysaccharide. The mass spectral analysis confirmed their identification along with a heterologous cross-reactivity which confirmed anti-Pn-24F mAb reactive to Pn 24B than Pn 24A. The quantitative analysis of pneumococcal 24A, 24B and 24F using GC-MS showed sensitive analysis over the concentration range 3.125-200 μg/mL with regression coefficient >0.99 making ideal modality for the characterization, identification, and quantitation of pneumococcal 24A, 24B and 24F similar serotypes.

Identifiants

pubmed: 38986261
pii: S0006-291X(24)00892-1
doi: 10.1016/j.bbrc.2024.150356
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

150356

Informations de copyright

Copyright © 2024 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest Authors declare that there is no competing interest for the work carried out as mentioned in the manuscript.

Auteurs

Niraj Shende (N)

Research and Development Department, Serum Institute of India Pvt Ltd., India.

Abhijeet Karale (A)

Research and Development Department, Serum Institute of India Pvt Ltd., India.

Hrishikesh Deshpande (H)

Research and Development Department, Serum Institute of India Pvt Ltd., India.

Hrushikesh Belapurkar (H)

Research and Development Department, Serum Institute of India Pvt Ltd., India.

Ashish Gulhane (A)

Research and Development Department, Serum Institute of India Pvt Ltd., India.

Sudhakar Bhagade (S)

Research and Development Department, Serum Institute of India Pvt Ltd., India.

Prashant Bore (P)

Research and Development Department, Serum Institute of India Pvt Ltd., India.

Dipen Soni (D)

Research and Development Department, Serum Institute of India Pvt Ltd., India.

Preeti Marathe (P)

Research and Development Department, Serum Institute of India Pvt Ltd., India.

Sushil Patni (S)

Research and Development Department, Serum Institute of India Pvt Ltd., India.

Rajeev Dhere (R)

Research and Development Department, Serum Institute of India Pvt Ltd., India.

Asha Mallya (A)

Research and Development Department, Serum Institute of India Pvt Ltd., India. Electronic address: asha.mallya@seruminstitute.com.

Classifications MeSH